Showing posts with label Healthcare Sector Industry Report. Show all posts
Showing posts with label Healthcare Sector Industry Report. Show all posts

Thursday, July 5, 2018

Rise Of Telemedicine Healthcare Market Outlook-Ken Research


Telemedicine is the use of information technology and telecommunication to provide clinical healthcare from a distance. Telemedicine has been prevalent since the last decade but has seen a huge upsurge in the recent years across the global healthcare sector. Telemedicine is a revolutionalizing technology that provides healthcare right at the doorstep of the patient. Telemedicine makes use of technology like emails, phones, video conferencing and for exchanging the medical information of the patient with the healthcare provider. Health Care Market Research Reports views the global telemedicine industry to grow at a CAGR of approximately 18.4% for the period of 2017-2022. This technology is being extensively used by elderly people and a patient suffering from chronic diseases for whom travelling to hospitals or clinics is not viable given their condition. The use of this technology has also been expanded to rural areas where adequate healthcare system is not in place and even involving critical situations requiring expert advice.

Telemedicine is highly beneficial for people in remote areas of the world where proper healthcare setup is not in place. People can make great use of this technology to consult doctors and healthcare providers without having to travel all the way to these far off locations. Health Care Industry Analysis reveals that there have been many instances where the disease has been transmitted from the patient to the medical staff. Technology such as telemedicine has eliminated the risk factor keeping the medical staff out of harm’s way. Remote monitoring and analysis services and electronic data storage significantly reduce the healthcare cost for both the providers and the patients. Telemedicine also reduces the non-urgent ER room visits and eliminates transportation expenses for regular expenses thus driving up revenue. Researchers suggest that an ageing population is one of the main reasons driving the growth of this industry. Currently, one in seven people currently in the US are above the age of 65 or above. By 2040, this number is expected to double comprising more than 20% of the population. With a huge elderly population, the growth of this industry is inevitable. Combined with these demographics, the increasing unhealthy modern lifestyle has slowly increased the population’s vulnerability to chronic diseases. In order to tap on this opportunity, healthcare providers are looking for ways to improve efficiency and while simultaneously reducing the number of physical infrastructure which can be easily accomplished with the help of telemedicine. Hence, this has also caused the telemedicine industry to boom.

The top companies operating in the telemedicine industry are Careclix (US), Doctor on Demand (US), Mytelemedicine (US), Teladoc (US) and icliniq (US). icliniq Is currently operational in India via its Bangalore and Coimbatore office. Telemedicine has also laid down its foot in the Indian market with major firms namely Gem3S Technologies, Global Med, HD Medical and Indian Health Organization. These companies are at the top of their market however; this is just the top of the iceberg. There are numerous international and national companies operating in this domain.
With the key growth drivers having an impact on this industry, the scope of this sector could prove to be limitless. In the future, the mobile technology will play a key role, with patients accessing live video doctors on their smart phones. Telemedicine doctors will be able to call up the health records with the touch of a finger while shifting seamlessly between physical and virtual waiting rooms.

To know more, click on the link below:

Related Report:

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249

Monday, July 2, 2018

Advancements In Stem Cell Research Market Outlook-Ken Research


Advancements in medicine have led us to a time where there are options available to regenerate organs. Stem cell surgery is the use of stem cells to treat ailments and is gaining popularity for its ability to regenerate body tissue. Healthcare market research report consulting shows that it already has wide ranged uses in orthopedics, blood cell formation and brain and spinal cord injuries. Its application on the heart is also being extensively researched. Heart failure occurs when the heart does not pump sufficient blood to maintain bodily functions.

Heart Failure is a chronic disease needing lifelong management however, with treatment signs and symptoms can improve even making the heart stronger sometimes thereby helping you live longer and reducing your chance of dying suddenly. Doctors can sometimes correct heart failure by treating the underlying cause for example repairing a heart valve or controlling a fast heart rhythm may reverse heart failure. For most people though, treatment of heart failure involves a balance of the right medications and in some cases use of devices that help the heart beat and contract properly. Now a new research is being carried out to augment the use of stem cells in the process of treatment.  Clinical trial planning is underway at US based MedStar Heart & Vascular Institute to determine whether novel stem cell therapy will improve heart function for patients with heart failure. The trial will use CardioCell’s proprietary Mesenchymal Stem Cells (MSCs) manufactured by Stemedica. The goal is to improve outcomes in patients with heart failure and left ventricular assist devices (LVADs).

This research is a leap forward not only from the medical science perspective but also from a business standpoint. Healthcare business review indicates that the global stem cell market is expected to reach nearly USD 16 billion by 2025 growing at a CAGR of 9.4% approximately. This research has led to the partnership of three highly reputed US based institutions.  MedStar Heart & Vascular Institute is a national leader in research, diagnosis and treatment of cardiovascular disease and has been consistently ranked as one of the premier destinations for cardiac care in the region for more than 55 years. Stemedica Cell Technologies is a global leader in regenerative medicine that develops, manufactures and distributes adult allogeneic stem cell products and   houses more than 30 years of research and innovation. CardioCell is a global biotechnology company that explores therapeutic applications of stem cells and has an exclusive worldwide license from Stemedica Cell Technologies for the exploration of therapeutic cardiovascular indications including Chronic Heart Failure (CHF).

This research also proves that stem cells are gaining global interests. Stem cells are being used as building blocks for humans that are not only benefiting medical science by increasing its scope but also paving the way for further research and discoveries. Big medical companies are actively investing in the bright future of stem cells and this is evident by the research project being carried out by MedStar Heart & Vascular Institute. Technologically advanced countries are constantly attempting to increase the utility from stem cell products which is the main growth driver with the US being at the forefront of this movement.

To know more, click on the link below:

Related Report:

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249

Thursday, June 28, 2018

Optical Diabetes Detection Market Outlook-Ken Research


Diabetes is among the most rapidly rising ailments today. Market research reports for healthcare estimate that around 390 million people could possibly be suffering from diabetes with half of them not being properly diagnosed at global level. Already developed equipment for easily testing blood sugar level at home involves a drop of blood. More research has now led to simple devices that perform the same function without having to prick the finger for blood. The medical field is highly incorporating technological developments into its procedures. Furthermore, big tech giants like Google are also working towards integration of technology and medicine. One of the results of this is the Google Contact Lens.

Until recently most of the devices that were used to check the blood sugar level relied on a drop of blood. This drop when fed into the device would generate the result. Healthcare industry research reports reveal that devices like Accu Check and blood sugar test strips are popular. Google has now moved beyond the primary requirement for blood whilst retaining functionality. Google Contact Lenses do not require blood but instead rely on tears and water released from eyes for calculating and monitoring the glucose level whilst enhancing the vision of the wearer. The lens consists of a wireless chip and a miniaturized glucose sensor. A tiny pin hole in the lens allows the tear fluid to seep into the sensor to measure the blood sugar level. Both of the sensors are embedded between two soft layers of lens material. The electronics lie outside of both the pupil and the iris so there is no damage to the eye. The wireless antenna present in each lens communicates the information to a wireless device. The prototype being tested can generate a reading once per second. Smart contact lenses are one of the most anticipated IoT (Internet of Things) technologies. Similar developments are taking place in certain regions around the world where the companies have managed to get patenets.

Scientists from Uisan National Institute of Science and Technology in South Korea have developed a soft and flexible contact lens that will allow diabetics to monitor their blood sugar level with the blink of an eye by analyzing their tears and using LED pixels in the device. The developers have laid extra focus on improving vision and comfort of the wearer.

Oregon State University professors from the US are researching a bio sensing contact lens that has an ultra sensitive bio sensor that can detect the lowest glucose concentrations present in tears. After being fully developed the technology would transfer the information to a smart phone or other WI-FI/Bluetooth devices. Swiss pharmaceutical giant Novartis teamed up with Google to develop the Google Contact Lens. Many other companies are also planning to enter the sphere of smart contact lenses despite modest developments. Google’s development is leading the way for several others. Technology is being developed that will work in similar fashion and detect oxygen levels, pulse rate and even the presence of cancer.

From an analysis of ongoing research we can conclude that there are two main objectives of modern technology which are firstly, to increase monitoring and secondly, to integrate technology and medicine. The researches that best prove this fact are being carried out by some of the most technologically advanced countries in the world led by the US and South Korea.

To know more, click on the link below:

Related Report:

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249

Tuesday, June 26, 2018

Telemedicine: Giant Leap For Healthcare Market Outlook-Ken Research


Healthcare sector has become of the world’s largest sector- both in terms of revenue and employment. Healthcare industry comprises of providers of diagnostic, preventive, remedial, and therapeutic services such as doctors, nurses, hospital, medical devices and equipments, clinical trials, telemedicine, medical tourism, health insurance and pharmaceutical manufacturers. Medicine plays a very important role in protecting, restoring and maintaining one’s life so it is prerequisite to have adequate quantity and superior quality at a reasonable rate therefore has become concern of global and national policy makers to fulfill the needs. Especially in rural or undeveloped parts of the country it has become necessary to initiate a system that could provide specialized pocket friendly medication. Health Care Market Research Reports state that Telemedicine solved the issue as it used telecommunication and information technology to deliver healthcare services where distance and inadequate infrastructure act as a barrier.

Over these years Telemedicine has transformed into complex integrated service used in homes, hospitals and private clinics. Healthcare has grown immensely since telemedicine injection because of its phenomenal characteristic to respond to medical emergencies by sharing expertise medical consultation and patient health records without delay in remote areas as well as urban. Telepsychiatry is one of the leading fields in Telemedicine as it brings expertise psychological treatment to patients remotely by experienced psychiatrist to their door step. There is quickly and timely follow up of patients along with maintaining their computerized comprehensive data. The modes of Telepsychiatry communication are:
Ø  Synchronous-mimic face to face
Ø  Asynchronous-non real time, store and forward
Ø  Through cell phones, mails, online chats, blogs etc

Telepsychiatry works in a setting where there is either just patient or psychiatrist interact virtually or in present of family or under surveillance of some other psychiatrist so that patient is safe and don’t harm him. Telepsychiatry deals with the treatment of depression disorders, panic disorders, agoraphobia, and social phobia and anxiety issues. It gives shy patient sense of confidence and comfort level without exposing that they are seeking psychological help which let them express their psychological state without any fear of being judged. Health Care Industry Analysis states positive outcome in terms of acceptability and satisfaction of this type of medication which is of reasonable cost as well as reliable. There are many institution and hospital supporting telepsychiatry for example in India it is actively supported by Apollo Hospital, cherry on the cake where south India involved mobile telepsychiatry unit with video-conferencing facility to cater one district and In America JSA health Telepsychiatry has been initiated.

Most Tele Psychiatry projects have been reported from the developed nation like America, Australia, Canada and certain Europe Countries. In developing countries like India is at its preliminary stage. Telepsychiatry holds the potential to solve the enormous and intertwined problems of under diagnosing and under treating persons with mental illness and the lack of trained manpower at grassroots level. With the growth in practice of Telepsychiatry it is expected to become more diagnostically reliable, efficient and cost effective according to the needs and resources of developed nation. Telepsychiatry has become feasible alternative for the existing and grossly scarce mental health services.

To know more, click on the link below:

Related Report:

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249